Skip to main content

Table 1 Summary of the baseline collected information

From: Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates

Category

Collected information

Sub-information

Demographics

Gender

 
 

Year of Birth

 
 

Height (cm)

 
 

Weight (kg)

 
 

Highest completed education

 
 

Country of Origin

 
 

Ethnicity

 

Health behavior

Smoking status: (Current, former, Never)

 
 

Smoking duration (days)

 
 

Smoking intensity (Packets/day)

 
 

Alcohol Consumption: (Current, former, Never)

 
 

Alcohol intensity (Units/week)

 
 

Physical activity (exercise times/week)

 

Physical examination & signs at recruitment

Blood Pressure (mmHg)

 
 

Pulse (beats/min)

 

Current diagnosis

Inpatient

Date of admission

  

Reason of admission

  

Recent interventional procedure

 

Outpatient

Type of visit (first, follow-up, after intervention)

  

Chief complaint

Study drugs

Which drug was the patient prescribed and recruited for (Clopidogrel, Warfarin, Atorvastatin, Rosuvastatin)

Start date

  

Clinically recommended dose

Medical History

Major cardiac events

 
 

Neurovascular events

 
 

Other vascular events

 
 

Other morbidities

 
 

Surgery/intervention history

 

Family History

Significant diseases in the family

 

Concomitant medications

Check-box list of the medications available in the local market

 

Laboratory Investigations

The most recent clinical laboratory investigations results (blood cholesterol, complete blood counts, and electrolytes)

Â